1 Aprepitant Market Overview 1.1 Product Overview and Scope of Aprepitant 1.2 Aprepitant Segment by Type 1.2.1 Global Aprepitant Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Injection 1.2.3 Oral 1.3 Aprepitant Segment by Application 1.3.1 Global Aprepitant Sales Comparison by Application: (2021-2027) 1.3.2 Hospital 1.3.3 Drug store 1.4 Global Aprepitant Market Size Estimates and Forecasts 1.4.1 Global Aprepitant Revenue 2016-2027 1.4.2 Global Aprepitant Sales 2016-2027 1.4.3 Aprepitant Market Size by Region: 2016 Versus 2021 Versus 2027 2 Aprepitant Market Competition by Manufacturers 2.1 Global Aprepitant Sales Market Share by Manufacturers (2016-2021) 2.2 Global Aprepitant Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Aprepitant Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Aprepitant Manufacturing Sites, Area Served, Product Type 2.5 Aprepitant Market Competitive Situation and Trends 2.5.1 Aprepitant Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Aprepitant Players Market Share by Revenue 2.5.3 Global Aprepitant Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Aprepitant Retrospective Market Scenario by Region 3.1 Global Aprepitant Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Aprepitant Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Aprepitant Market Facts & Figures by Country 3.3.1 North America Aprepitant Sales by Country 3.3.2 North America Aprepitant Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Aprepitant Market Facts & Figures by Country 3.4.1 Europe Aprepitant Sales by Country 3.4.2 Europe Aprepitant Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Aprepitant Market Facts & Figures by Region 3.5.1 Asia Pacific Aprepitant Sales by Region 3.5.2 Asia Pacific Aprepitant Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Aprepitant Market Facts & Figures by Country 3.6.1 Latin America Aprepitant Sales by Country 3.6.2 Latin America Aprepitant Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Aprepitant Market Facts & Figures by Country 3.7.1 Middle East and Africa Aprepitant Sales by Country 3.7.2 Middle East and Africa Aprepitant Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Aprepitant Historic Market Analysis by Type 4.1 Global Aprepitant Sales Market Share by Type (2016-2021) 4.2 Global Aprepitant Revenue Market Share by Type (2016-2021) 4.3 Global Aprepitant Price by Type (2016-2021) 5 Global Aprepitant Historic Market Analysis by Application 5.1 Global Aprepitant Sales Market Share by Application (2016-2021) 5.2 Global Aprepitant Revenue Market Share by Application (2016-2021) 5.3 Global Aprepitant Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Merck & Co. 6.1.1 Merck & Co. Corporation Information 6.1.2 Merck & Co. Description and Business Overview 6.1.3 Merck & Co. Aprepitant Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Merck & Co. Aprepitant Product Portfolio 6.1.5 Merck & Co. Recent Developments/Updates 6.2 Heron Therapeutics 6.2.1 Heron Therapeutics Corporation Information 6.2.2 Heron Therapeutics Description and Business Overview 6.2.3 Heron Therapeutics Aprepitant Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Heron Therapeutics Aprepitant Product Portfolio 6.2.5 Heron Therapeutics Recent Developments/Updates 6.3 Sandoz 6.3.1 Sandoz Corporation Information 6.3.2 Sandoz Description and Business Overview 6.3.3 Sandoz Aprepitant Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Sandoz Aprepitant Product Portfolio 6.3.5 Sandoz Recent Developments/Updates 6.4 Glenmark Pharmaceuticals 6.4.1 Glenmark Pharmaceuticals Corporation Information 6.4.2 Glenmark Pharmaceuticals Description and Business Overview 6.4.3 Glenmark Pharmaceuticals Aprepitant Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Glenmark Pharmaceuticals Aprepitant Product Portfolio 6.4.5 Glenmark Pharmaceuticals Recent Developments/Updates 7 Aprepitant Manufacturing Cost Analysis 7.1 Aprepitant Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Aprepitant 7.4 Aprepitant Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Aprepitant Distributors List 8.3 Aprepitant Customers 9 Aprepitant Market Dynamics 9.1 Aprepitant Industry Trends 9.2 Aprepitant Growth Drivers 9.3 Aprepitant Market Challenges 9.4 Aprepitant Market Restraints 10 Global Market Forecast 10.1 Aprepitant Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Aprepitant by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Aprepitant by Type (2022-2027) 10.2 Aprepitant Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Aprepitant by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Aprepitant by Application (2022-2027) 10.3 Aprepitant Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Aprepitant by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Aprepitant by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Aprepitant Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Aprepitant Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Aprepitant Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Aprepitant Covered in This Study Table 5. Global Aprepitant Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Aprepitant Sales Market Share by Manufacturers (2016-2021) Table 7. Global Aprepitant Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Aprepitant Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Aprepitant Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Aprepitant Manufacturing Sites and Area Served Table 11. Manufacturers Aprepitant Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Aprepitant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aprepitant as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Aprepitant Sales by Region (2016-2021) & (K Units) Table 16. Global Aprepitant Sales Market Share by Region (2016-2021) Table 17. Global Aprepitant Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Aprepitant Sales by Country (2016-2021) & (K Units) Table 19. North America Aprepitant Sales Market Share by Country (2016-2021) Table 20. North America Aprepitant Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Aprepitant Revenue Market Share by Country (2016-2021) Table 22. Europe Aprepitant Sales by Country (2016-2021) & (K Units) Table 23. Europe Aprepitant Sales Market Share by Country (2016-2021) Table 24. Europe Aprepitant Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Aprepitant Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Aprepitant Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Aprepitant Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Aprepitant Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Aprepitant Revenue Market Share by Region (2016-2021) Table 30. Latin America Aprepitant Sales by Country (2016-2021) & (K Units) Table 31. Latin America Aprepitant Sales Market Share by Country (2016-2021) Table 32. Latin America Aprepitant Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Aprepitant Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Aprepitant Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Aprepitant Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Aprepitant Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Aprepitant Revenue Market Share by Country (2016-2021) Table 38. Global Aprepitant Sales (K Units) by Type (2016-2021) Table 39. Global Aprepitant Sales Market Share by Type (2016-2021) Table 40. Global Aprepitant Revenue (Million US$) by Type (2016-2021) Table 41. Global Aprepitant Revenue Share by Type (2016-2021) Table 42. Global Aprepitant Price (USD/Unit) by Type (2016-2021) Table 43. Global Aprepitant Sales (K Units) by Application (2016-2021) Table 44. Global Aprepitant Sales Market Share by Application (2016-2021) Table 45. Global Aprepitant Revenue (Million US$) by Application (2016-2021) Table 46. Global Aprepitant Revenue Share by Application (2016-2021) Table 47. Global Aprepitant Price (USD/Unit) by Application (2016-2021) Table 48. Merck & Co. Corporation Information Table 49. Merck & Co. Description and Business Overview Table 50. Merck & Co. Aprepitant Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Merck & Co. Aprepitant Product Table 52. Merck & Co. Recent Developments/Updates Table 53. Heron Therapeutics Corporation Information Table 54. Heron Therapeutics Description and Business Overview Table 55. Heron Therapeutics Aprepitant Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Heron Therapeutics Aprepitant Product Table 57. Heron Therapeutics Recent Developments/Updates Table 58. Sandoz Corporation Information Table 59. Sandoz Description and Business Overview Table 60. Sandoz Aprepitant Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Sandoz Aprepitant Product Table 62. Sandoz Recent Developments/Updates Table 63. Glenmark Pharmaceuticals Corporation Information Table 64. Glenmark Pharmaceuticals Description and Business Overview Table 65. Glenmark Pharmaceuticals Aprepitant Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Glenmark Pharmaceuticals Aprepitant Product Table 67. Glenmark Pharmaceuticals Recent Developments/Updates Table 68. Production Base and Market Concentration Rate of Raw Material Table 69. Key Suppliers of Raw Materials Table 70. Aprepitant Distributors List Table 71. Aprepitant Customers List Table 72. Aprepitant Market Trends Table 73. Aprepitant Growth Drivers Table 74. Aprepitant Market Challenges Table 75. Aprepitant Market Restraints Table 76. Global Aprepitant Sales Forecast by Type (2022-2027) & (K Units) Table 77. Global Aprepitant Sales Market Share Forecast by Type (2022-2027) Table 78. Global Aprepitant Revenue Forecast by Type (2022-2027) & (US$ Million) Table 79. Global Aprepitant Revenue Market Share Forecast by Type (2022-2027) Table 80. Global Aprepitant Sales Forecast by Application (2022-2027) & (K Units) Table 81. Global Aprepitant Sales Market Share Forecast by Application (2022-2027) Table 82. Global Aprepitant Revenue Forecast by Application (2022-2027) & (US$ Million) Table 83. Global Aprepitant Revenue Market Share Forecast by Application (2022-2027) Table 84. Global Aprepitant Sales Forecast by Region (2022-2027) & (K Units) Table 85. Global Aprepitant Sales Market Share Forecast by Region (2022-2027) Table 86. Global Aprepitant Revenue Forecast by Region (2022-2027) & (US$ Million) Table 87. Global Aprepitant Revenue Market Share Forecast by Region (2022-2027) Table 88. Research Programs/Design for This Report Table 89. Key Data Information from Secondary Sources Table 90. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Aprepitant Figure 2. Global Aprepitant Market Share by Type in 2020 & 2027 Figure 3. Injection Product Picture Figure 4. Oral Product Picture Figure 5. Global Aprepitant Market Share by Application in 2020 & 2027 Figure 6. Hospital Figure 7. Drug store Figure 8. Global Aprepitant Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Aprepitant Market Size 2016-2027 (US$ Million) Figure 10. Global Aprepitant Sales 2016-2027 (K Units) Figure 11. Global Aprepitant Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 12. Aprepitant Sales Share by Manufacturers in 2020 Figure 13. Global Aprepitant Revenue Share by Manufacturers in 2020 Figure 14. The Global 5 and 10 Largest Aprepitant Players: Market Share by Revenue in 2020 Figure 15. Aprepitant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 16. Global Aprepitant Sales Market Share by Region (2016-2021) Figure 17. Global Aprepitant Sales Market Share by Region in 2020 Figure 18. Global Aprepitant Revenue Market Share by Region (2016-2021) Figure 19. Global Aprepitant Revenue Market Share by Region in 2020 Figure 20. U.S. Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 21. Canada Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Germany Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. France Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. U.K. Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Italy Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Russia Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. China Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Japan Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. South Korea Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. India Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Australia Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Taiwan Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Indonesia Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Thailand Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Malaysia Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Philippines Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Vietnam Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Mexico Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Brazil Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Argentina Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Turkey Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Saudi Arabia Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. U.A.E Aprepitant Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Sales Market Share of Aprepitant by Type (2016-2021) Figure 45. Sales Market Share of Aprepitant by Application (2016-2021) Figure 46. Sales Market Share of Aprepitant by Application in 2020 Figure 47. Revenue Share of Aprepitant by Application (2016-2021) Figure 48. Revenue Share of Aprepitant by Application in 2020 Figure 49. Manufacturing Cost Structure of Aprepitant Figure 50. Manufacturing Process Analysis of Aprepitant Figure 51. Aprepitant Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Merck & Co. Heron Therapeutics Sandoz Glenmark Pharmaceuticals